secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACS Group, Inc. (PACS)
CIK:        0002001184
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0002001184-24-000037
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PACS Group Q2 revenue $981.8M (+29% YoY); GAAP net loss $10.9M on $90.9M IPO stock comp; raises FY2024 guidance
--------------------------------------------------------------------------------

- GAAP net loss of $10.9M for Q2 2024 due to $90.9M stock-based compensation from IPO RSU grants.
- Revenue $981.8M, up 29% YoY and 5% sequentially; patient days grew 24.8% YoY.
- Adjusted EBITDA $99.7M in Q2; full-year guidance raised to revenue $3.85-3.95B and Adj. EBITDA $370-380M.
- Occupancy 91.0%; average Medicare daily rate up 9.5% and Medicaid up 3.5% YoY.
- Added 28 facilities post-Q2, now operating 248 facilities across 13 states; real estate assets owned/through JV total 87.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2001184/000200118424000037/0002001184-24-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2001184/000200118424000037/pacs-20240812.htm
  HTML page:      https://secwatch.observer/filing/0002001184-24-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer